Canada · Health Canada Drug Product Database

SANDOZ SITAGLIPTIN-METFORMIN XR

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 101831
DIN: 02529122
Form: Tablet (Extended-Release)
Company as listed by source: SANDOZ CANADA INCORPORATED
Source status: Marketed (2023-03-22)
Source last updated: 2025-03-22

Source-listed ingredients

SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) — 100 MG
METFORMIN HYDROCHLORIDE — 1000 MG

These values do not establish equivalence or a dose recommendation.

Packages

Package details are not available in this snapshot.

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →